EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Application of Preconception Expanded Carrier Screening in Assisted Reproductive Technology Populations in Central China

Chun Chen, Hailong Li, Beibei Shen, Xiaoyue Peng, Kui Fu, Zixuan Wang, Ying Zhang, Zhifeng Sun

Clinical and Experimental Obstetrics & Gynecology · 17.07.2026 · 53 (7)

DOI: 10.31083/ceog45679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 17.07.2026. Verfasst von Chun Chen und 7 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Student Innovation and Entrepreneurship Training Program, Hubei University of Medicine “14th Five-Year Plan” Provincial Advantage Specialty Discipline Group, Innovation Research Program For Graduates of The biomedical engineering, Hubei University of Medicine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the clinical application of preconception expanded carrier screening (PECS) in couples undergoing assisted reproductive technology (ART) in Central China.

Methods

We conducted a retrospective study at the Reproductive Medicine Center of Shiyan Renmin Hospital from August 2022 to November 2023. PECS results from infertile couples were analyzed to determine carrier rates for pathogenic single-gene variants and the proportion of at-risk couples (ARCs). Identified ARCs received genetic counseling and reproductive guidance, and pregnancy outcomes were assessed.

Results

A total of 4853 patients (2082 couples) underwent PECS for 22 monogenic diseases. Among them, 81.58% (3959/4853) carried no pathogenic variants, whereas 18.42% (894/4853) carried at least one variant. The carrier rates for one, two, and three variants were 16.73%, 1.61%, and 0.08%, respectively. The genes with the highest carrier frequencies were gap junction protein beta 2 (GJB2) (3.05%), cytochrome P450 family 21 subfamily A member 2 (CYP21A2) (2.64%), hemoglobin subunit alpha 1/2 (HBA1/HBA2) (2.12%), survival of motor neuron 1 (SMN1) (2.12%), and ATPase copper transporting beta (ATP7B) (2.10%). ARCs were identified in 2.31% (48/2082) of couples. Of these, 1 couple chose preimplantation genetic testing for monogenic disorders (PGT-M), and another opted for preimplantation genetic testing for aneuploidy (PGT-A). 26 couples proceeded with routine ART, which resulted in 14 live births. Outcomes among the remaining ARCs included 4 canceled embryo transfer cycles, 3 failed pregnancies, 3 early miscarriages, and 2 elective terminations.

Conclusions

PECS provides a valuable approach to identify single-gene disease risks in the infertile population of Central China. It facilitates informed reproductive decision-making and supports the prevention of affected offspring through targeted prenatal diagnosis.

Förderung

  • University Student Innovation and Entrepreneurship Training Program
  • Hubei University of Medicine “14th Five-Year Plan” Provincial Advantage Specialty Discipline Group
  • Innovation Research Program For Graduates of The biomedical engineering, Hubei University of Medicine

Zitieren

APA

Chen, C., Li, H., Shen, B., Peng, X., Fu, K., Wang, Z., Zhang, Y., & Sun, Z. (2026). Clinical Application of Preconception Expanded Carrier Screening in Assisted Reproductive Technology Populations in Central China. Clinical and Experimental Obstetrics & Gynecology, 53(7). https://doi.org/10.31083/ceog45679

Vancouver

Chen C, Li H, Shen B, Peng X, Fu K, Wang Z, et al. Clinical Application of Preconception Expanded Carrier Screening in Assisted Reproductive Technology Populations in Central China. Clinical and Experimental Obstetrics & Gynecology. 2026;53(7). doi:10.31083/ceog45679

BibTeX
@article{Chen2026,
  author = {Chen, Chun and Li, Hailong and Shen, Beibei and Peng, Xiaoyue and Fu, Kui and Wang, Zixuan and Zhang, Ying and Sun, Zhifeng},
  title = {Clinical Application of Preconception Expanded Carrier Screening in Assisted Reproductive Technology Populations in Central China},
  journal = {Clinical and Experimental Obstetrics & Gynecology},
  year = {2026},
  volume = {53},
  number = {7},
  doi = {10.31083/ceog45679}
}
Kostenlos starten →